grants awardedPreviously funded grants have included: Cincinnati Children's Hospital Medical Center - $155,000 (January 2012)Establishment of an International DIPG RegistryGrant Information ![]() Thank You Letter
Texas Children's Hospital - $100,000 (November 2011)Eliminating Therapy–Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001: an in vivo Study in Intra-brain Stem Xenograft Mouse ModelsGrant Information ![]() Thank You Letter
Duke Children's Hospital & Health Center - $82,049 (November 2011) Preclinical evaluation of systemic and direct delivery of a PDGFR-alpha antibodyGrant Information ![]() Thank You Letter
Doernbecher Children's Hospital - $100,000 (November 2011)Rapid Preclinical Development of a Targeted Therapy Combination for DIPGGrant Information ![]() Thank You Letter
Sydney Children's Hospital - $100,000 (August 2011)Rapid Development of Targeted TherapiesGrant Information ![]() Media Release
St. Jude Children's Research Hospital - $35,000 (September 2010)Signaling Effectors in Diffuse Intrinsic Potine Glioma (DIPG)Grant Information ![]() Thank You Letter
Cincinnati Children's Hospital Medical Center - $35,000
Establishment of a pre-clinical model for prediatric glioblastoma |
2nd Annual Bowling For a Cure: April 14, 2012 at Cold Country Lanes in Sutter Creek, CA. |




Preclinical evaluation of systemic and direct delivery of a PDGFR-alpha antibody
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
A multi-institutional study in which an extensive analysis of the genetic make-up of brainstem gliomas will be performed to gain a better understanding of the underlying genetic abnormalities.


